XBIOTECH INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8d99506e-d0d3-446e-9480-4562f83dfb3b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001171843-24-001382 |
| FY 2022 | $4.0M | 2022-01-01 – 2022-12-31 | evidence 0001171843-23-001705 |
| FY 2021 | $18.4M | 2021-01-01 – 2021-12-31 | evidence 0001171843-22-001904 |
| FY 2020 | $44.0M | 2020-01-01 – 2020-12-31 | evidence 0001171843-21-001828 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001171843-21-001828 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001171843-21-001828 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).